Binding of the NG2 proteoglycan to type VI collagen and other extracellular matrix molecules - Wikidata - awgldk - TriplyDB

Binding of the NG2 proteoglycan to type VI collagen and other extracellular matrix molecules

Binding of the NG2 proteoglycan to type VI collagen and other extracellular matrix molecules

http://www.wikidata.org/entity/Q28291052

about

The membrane-spanning proteoglycan NG2 binds to collagens V and VI through the central nonglobular domain of its core protein Crystal structure and mapping by site-directed mutagenesis of the collagen-binding epitope of an activated form of BM-40/SPARC/osteonectin NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis The multi-PDZ domain protein MUPP1 is a cytoplasmic ligand for the membrane-spanning proteoglycan NG2 NG2 proteoglycan and the actin-binding protein fascin define separate populations of actin-containing filopodia and lamellipodia during cell spreading and migration Collagen VI related muscle disorders The Role of NG2 Proteoglycan in Glioma Transcriptome Analysis of Ullrich Congenital Muscular Dystrophy Fibroblasts Reveals a Disease Extracellular Matrix Signature and Key Molecular Regulators Targeting activated hepatic stellate cells (aHSCs) for liver fibrosis imaging Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy.Biglycan and decorin bind close to the n-terminal region of the collagen VI triple helix.Biglycan organizes collagen VI into hexagonal-like networks resembling tissue structures.Characterization of the secreted proteome of rat hepatocytes cultured in collagen sandwiches.Contribution of bone marrow-derived pericyte precursor cells to corneal vasculogenesis.Targeting pericytes diminishes neovascularization in orthotopic uveal melanoma in nerve/glial antigen 2 proteoglycan knockout mouse Three-dimensional architecture of collagen type VI in the human trabecular meshwork Matrix regulators in neural stem cell functions.Identification of cell surface glycoprotein markers for glioblastoma-derived stem-like cells using a lectin microarray and LC-MS/MS approach.CSPG4: a prototype oncoantigen for translational immunotherapy studies.The collagen VI-related myopathies Ullrich congenital muscular dystrophy and Bethlem myopathy.Mitochondrial dysfunction and defective autophagy in the pathogenesis of collagen VI muscular dystrophies.Proteoglycans in Normal and Healing Skin.WARP interacts with collagen VI-containing microfibrils in the pericellular matrix of human chondrocytes.Novel frem1-related mouse phenotypes and evidence of genetic interactions with gata4 and slit3.Extracellular regulators of axonal growth in the adult central nervous system ColVI myopathies: where do we stand, where do we go?The emerging role of NG2 in pediatric diffuse intrinsic pontine glioma.Evidence for additional FREM1 heterogeneity in Manitoba oculotrichoanal syndrome.Differential phosphorylation of NG2 proteoglycan by ERK and PKCalpha helps balance cell proliferation and migration.CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma NG2-expressing cells in the nervous system: role of the proteoglycan in migration and glial-neuron interaction.Collagen VI deficiency reduces muscle pathology, but does not improve muscle function, in the γ-sarcoglycan-null mouse Proteoglycans and their roles in brain cancer.NG2/CSPG4-collagen type VI interplays putatively involved in the microenvironmental control of tumour engraftment and local expansion.Cytoskeletal reorganization induced by engagement of the NG2 proteoglycan leads to cell spreading and migration A simple method for measuring interstitial fluid pressure in cancer tissues.Developmental and osteoarthritic changes in Col6a1-knockout mice: biomechanics of type VI collagen in the cartilage pericellular matrix.Advanced osteoarthritis in humans is associated with altered collagen VI expression and upregulation of ER-stress markers Grp78 and bag-1.A role for the NG2 proteoglycan in glioma progression.

P2860

Q24312863-16FE61CA-9078-41CB-A443-B6F4E94D2601 Q24317307-185DC4EB-CECC-45AA-B134-234344D57356 Q24561606-5B43A3F7-FE30-477E-B8D1-3EA4CED5C61A Q24564726-38FC6867-5CA2-4F56-AA66-64B8D1EB5AC2 Q24609951-693E20B4-6F6A-4373-BC32-BE4FBE78BD04 Q24654620-BF0C9CF3-5667-40F2-8110-4288B26011D5 Q24673264-5039982D-2827-4C16-8607-FE6CF4010502 Q26767702-7AC64739-F069-43E8-BC0A-73D16731C1B5 Q28271052-01617D30-0CFE-4F57-AF9C-02D0E6D22C5E Q30395463-B66338F0-4F70-4931-87D4-97340DF604F0 Q30478574-E104C793-7815-44C3-A7BD-CC59ECBD19DE Q30659690-AF8A252B-FEB3-4959-A3F0-7AAA21D01595 Q30857848-2E32A530-ACC9-4CC0-A068-27D03E71794F Q33219624-E2D2138C-3221-4BE6-8555-C9EE6D6BA5FB Q33223998-889DC5D8-08D0-484C-8430-57B9B2F88BD7 Q33252817-243B1086-E8BA-4164-AE0F-54B2EC2BA402 Q33614289-312FD587-C306-416B-9D26-F06695EB1E5F Q33819268-FC530F50-111F-4886-9731-A58681FD6598 Q33835228-0715CEAF-7F5B-4A8E-9041-28084B7E9AD2 Q33862585-FDFB7645-67FE-4CFF-BC26-A4841E813308 Q34178677-DEAC4007-DB6E-4ADA-BC0C-BEECFC6BFCA9 Q34338854-5E9DDE5D-8126-4C0A-9B6D-69DD8F0BC7F9 Q34467680-DA8F50AD-70E2-45AD-B233-F52B84E5EAD1 Q34541228-F682ED54-AC16-4A31-B3BD-91D4AAA5F717 Q34639401-6F2FAA72-2F07-4CC9-9F4E-E70A1CD9D88C Q35172113-AE2255EA-F624-48D3-B5C7-D40383CC5BF5 Q35290709-660D6A9E-FA60-4EAD-9377-D3DEE4863276 Q35828522-D4854F4B-CEDD-4CE6-88E9-041EE8511A1D Q36015804-2F9B1DF9-2E2E-4A8F-BA77-7930F4466C0A Q36118785-935F114D-2ADB-4616-8576-5D7027B0ED3E Q36295924-0B1475D3-AEC1-40B8-81CC-8C3C19831016 Q36347835-DB648E96-BB3C-447A-8734-BC15371A1639 Q36676817-F0D0BEC1-6E2E-48EF-9166-AC5A7626F7B8 Q36816444-6B98B600-F097-467F-80CC-9C89A862BBB7 Q36851314-9A60A7ED-A659-4294-B150-BF95C2F63CD2 Q36921010-C044917A-35FC-4027-8195-FB0463408AAA Q37207583-0A9C6317-CCD2-4030-A843-4E8F7EED08A0 Q37299986-B781E4B2-ECA0-407B-A69F-5AFB90D6654E Q37353085-604118F0-9CD7-4A13-8870-6D85189FC24C Q37406681-AAE0BA83-2AF3-4D65-9DB0-2680B639A083

P2860

Binding of the NG2 proteoglycan to type VI collagen and other extracellular matrix molecules

http://www.wikidata.org/entity/Q28291052

description

1996 nî lūn-bûn

@nan

1996 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

Binding of the NG2 proteoglyca ...... extracellular matrix molecules

@ast

Binding of the NG2 proteoglyca ...... extracellular matrix molecules

@en

Binding of the NG2 proteoglyca ...... extracellular matrix molecules

@nl

type

label

Binding of the NG2 proteoglyca ...... extracellular matrix molecules

@ast

Binding of the NG2 proteoglyca ...... extracellular matrix molecules

@en

Binding of the NG2 proteoglyca ...... extracellular matrix molecules

@nl

prefLabel

Binding of the NG2 proteoglyca ...... extracellular matrix molecules

@ast

Binding of the NG2 proteoglyca ...... extracellular matrix molecules

@en

Binding of the NG2 proteoglyca ...... extracellular matrix molecules

@nl

P1433

Q28291052-A17A161F-5BCA-428B-AF08-760CD871F7B7

P1476

Q28291052-FECFDD34-4D32-4698-9C36-104FB0F6366B

P2093

Q28291052-2D271BBD-A05A-4C64-B57C-D50206DCE4F4

Q28291052-956A4E91-5BA2-4A5A-B13C-DE4A63FF1B39

Q28291052-DEE076A1-297C-4783-A82E-0E867DF44F7F

Q28291052-EB5E4145-9E9C-415B-97AD-B405EBC24E25

P2860

Q28291052-02918389-C7C6-45F0-A5DE-EB280098B8BA

Q28291052-04E83596-9AF0-48BF-8E62-24C7C32BCDE4

Q28291052-18B567E6-A0A0-4AD1-A8E4-6B06BEF6ECBF

Q28291052-1BF27ED8-6F21-4768-BD49-CBD45BBE20B2

Q28291052-2552BBC7-95ED-4755-BD4C-56D17188993C

Q28291052-2B44D147-7EF9-4974-97DE-4B705D6D0A9C

Q28291052-3D7C6966-6867-47E1-B101-732CC2EE3D3D

Q28291052-3E90B57D-B732-4E6B-9D18-739CE9FEC0D1

Q28291052-3E9ED09C-27FF-42C6-AC35-8C6A9431AC52

Q28291052-4831E248-2F8E-4001-BD6D-3E91490251B6

P304

Q28291052-A91334B0-2F3F-4F07-BC61-502B3F29A042

P31

Q28291052-B0762E9F-ED98-4D80-A298-B705D01ACB54

P356

Q28291052-156726BA-AE07-42E6-A839-B81DBD2026A7

P407

Q28291052-9FEB7699-3785-47F6-B0E3-B1555E0952D3

P433

Q28291052-A84F75BD-3F1F-49AC-957F-741BF5BDB902

P478

Q28291052-526DE87D-7D8F-4B22-8E7C-6303B1BD482B

P577

Q28291052-33B0B9A7-5D9E-4D40-9930-32DA388F5E17

P5875

Q28291052-165F0D9B-F573-4644-9F9C-717CEAE1B423

P698

Q28291052-FF5AC817-5A3C-4414-9FA8-6A52AC13E68F

P921

Q28291052-74D5C603-4B85-4416-B05E-6914083739C4

P356

JBC.271.42.26110

P1433

Journal of Biological Chemistry

P1476

Binding of the NG2 proteoglyca ...... extracellular matrix molecules

@en

P2093

E Tillet

http://www.w3.org/2001/XMLSchema#string

M A Burg

http://www.w3.org/2001/XMLSchema#string

R Timpl

http://www.w3.org/2001/XMLSchema#string

W B Stallcup

http://www.w3.org/2001/XMLSchema#string

P2860

Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues

150-kD von Willebrand factor binding protein extracted from human vascular subendothelium is type VI collagen

Expression of NG2 proteoglycan causes retention of type VI collagen on the cell surface

Recombinant expression and structural and binding properties of alpha 1(VI) and alpha 2(VI) chains of human collagen type VI

CD44 is the principal cell surface receptor for hyaluronate

Integrin and Arg-Gly-Asp dependence of cell adhesion to the native and unfolded triple helix of collagen type VI

Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins

Negative regulation of transforming growth factor-beta by the proteoglycan decorin

Expression of human proteoglycan in Chinese hamster ovary cells inhibits cell proliferation

Electron-microscopical approach to a structural model of intima collagen

P304

26110-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.271.42.26110

http://www.w3.org/2001/XMLSchema#string

P407

P433

42

http://www.w3.org/2001/XMLSchema#string

P478

271

http://www.w3.org/2001/XMLSchema#string

P577

1996-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14381606

http://www.w3.org/2001/XMLSchema#string

P698

8824254

http://www.w3.org/2001/XMLSchema#string

P921

extracellular matrix